Advanced search

Authors whose works are in public domain in at least one jurisdiction

List of works by Paul Emery

1-50 of 1061 results

2010 Rheumatoid arthritis classification criteria: An American College of Rheumatology/European League Against Rheumatism collaborative initiative

scholarly article by Daniel Aletaha et al published 10 August 2010 in Arthritis and Rheumatism

Infliximab and methotrexate in the treatment of rheumatoid arthritis. Anti-Tumor Necrosis Factor Trial in Rheumatoid Arthritis with Concomitant Therapy Study Group

scientific article (publication date: 30 November 2000)

Efficacy of B-cell-targeted therapy with rituximab in patients with rheumatoid arthritis

scientific article

EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2013 update

scientific article

2010 rheumatoid arthritis classification criteria: an American College of Rheumatology/European League Against Rheumatism collaborative initiative

scientific article

Infliximab (chimeric anti-tumour necrosis factor alpha monoclonal antibody) versus placebo in rheumatoid arthritis patients receiving concomitant methotrexate: a randomised phase III trial. ATTRACT Study Group

scientific article

Treating rheumatoid arthritis to target: recommendations of an international task force

scientific article

EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs

scientific article

Rituximab for rheumatoid arthritis refractory to anti-tumor necrosis factor therapy: Results of a multicenter, randomized, double-blind, placebo-controlled, phase III trial evaluating primary efficacy and safety at twenty-four weeks

scientific article published in September 2006

Genome-wide association study meta-analysis identifies seven new rheumatoid arthritis risk loci

scientific article

EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2016 update

scientific article published on 6 March 2017

Genome-wide association study of CNVs in 16,000 cases of eight common diseases and 3,000 shared controls

scientific article

IL-6 receptor inhibition with tocilizumab improves treatment outcomes in patients with rheumatoid arthritis refractory to anti-tumour necrosis factor biologicals: results from a 24-week multicentre randomised placebo-controlled trial

scientific article

Combination of infliximab and methotrexate therapy for early rheumatoid arthritis: a randomized, controlled trial

scientific article

2010 update of the ASAS/EULAR recommendations for the management of ankylosing spondylitis

scientific article

New therapies for treatment of rheumatoid arthritis

scientific article published on December 2007

Treatment of rheumatoid arthritis by selective inhibition of T-cell activation with fusion protein CTLA4Ig

scientific article published on 01 November 2003

Treatment of rheumatoid arthritis with recombinant human interleukin-1 receptor antagonist

scientific article published in December 1998

Treating rheumatoid arthritis to target: 2014 update of the recommendations of an international task force

scientific article published on 12 May 2015

A simplified disease activity index for rheumatoid arthritis for use in clinical practice

scientific article published in February 2003

EULAR recommendations for the management of early arthritis: report of a task force of the European Standing Committee for International Clinical Studies Including Therapeutics (ESCISIT).

scientific article published on 5 January 2006

Effects of abatacept in patients with methotrexate-resistant active rheumatoid arthritis: a randomized trial

scientific article published in June 2006

An explanation for the apparent dissociation between clinical remission and continued structural deterioration in rheumatoid arthritis

scholarly article by A. K. Brown et al published October 2008 in Arthritis and Rheumatism

The efficacy and safety of rituximab in patients with active rheumatoid arthritis despite methotrexate treatment: results of a phase IIB randomized, double-blind, placebo-controlled, dose-ranging trial

scientific article published on 01 May 2006

Presence of significant synovitis in rheumatoid arthritis patients with disease-modifying antirheumatic drug–induced clinical remission: Evidence from an imaging study may explain structural progression

article

Rheumatoid arthritis association at 6q23.

scientific article

American College of Rheumatology/European League Against Rheumatism provisional definition of remission in rheumatoid arthritis for clinical trials

scientific article

Birmingham Vasculitis Activity Score (BVAS) in systemic necrotizing vasculitis.

scientific article published in November 1994

Very early treatment with infliximab in addition to methotrexate in early, poor-prognosis rheumatoid arthritis reduces magnetic resonance imaging evidence of synovitis and damage, with sustained benefit after infliximab withdrawal: Results from a twe

article

Isolation and characterization of bone marrow multipotential mesenchymal progenitor cells

scientific article published on December 2002

The development of Assessment of SpondyloArthritis international Society classification criteria for axial spondyloarthritis (part I): classification of paper patients by expert opinion including uncertainty appraisal

scientific article published on 17 March 2009

Secukinumab, an Interleukin-17A Inhibitor, in Ankylosing Spondylitis

scientific article published in December 2015

Efficacy and safety of adalimumab as monotherapy in patients with rheumatoid arthritis for whom previous disease modifying antirheumatic drug treatment has failed

scientific article published on May 2004

Comparison of methotrexate monotherapy with a combination of methotrexate and etanercept in active, early, moderate to severe rheumatoid arthritis (COMET): a randomised, double-blind, parallel treatment trial

scientific article published on 16 July 2008

American College of Rheumatology/European League Against Rheumatism Provisional Definition of Remission in Rheumatoid Arthritis for Clinical Trials

scholarly article by D. T. Felson et al published 3 February 2011 in Annals of the Rheumatic Diseases

Prevalence of comorbidities in rheumatoid arthritis and evaluation of their monitoring: results of an international, cross-sectional study (COMORA).

scientific article published on 04 October 2013

Tocilizumab monotherapy versus adalimumab monotherapy for treatment of rheumatoid arthritis (ADACTA): a randomised, double-blind, controlled phase 4 trial

scientific article published on 18 March 2013

Psoriasis and systemic inflammatory diseases: potential mechanistic links between skin disease and co-morbid conditions

scientific article published on 06 May 2010

European League Against Rheumatism (EULAR) recommendations for the management of psoriatic arthritis with pharmacological therapies: 2015 update

scientific article

Anti-interleukin-17A monoclonal antibody secukinumab in treatment of ankylosing spondylitis: a randomised, double-blind, placebo-controlled trial

scientific article published on 13 September 2013

Generalised bone loss in patients with early rheumatoid arthritis

scientific article published on 01 July 1994

A multicenter, prospective, randomized, double-blind, placebo-controlled trial of corticosteroids and intravenous cyclophosphamide followed by oral azathioprine for the treatment of pulmonary fibrosis in scleroderma

scientific article

Treatment of rheumatoid arthritis with the selective costimulation modulator abatacept: twelve-month results of a phase iib, double-blind, randomized, placebo-controlled trial

scientific article

EULAR recommendations for vaccination in adult patients with autoimmune inflammatory rheumatic diseases

scientific article published on 03 December 2010

The value of sonography in the detection of bone erosions in patients with rheumatoid arthritis: a comparison with conventional radiography

scientific article

Genetic variants at CD28, PRDM1 and CD2/CD58 are associated with rheumatoid arthritis risk

scientific article

Certolizumab pegol plus methotrexate is significantly more effective than placebo plus methotrexate in active rheumatoid arthritis: findings of a fifty-two-week, phase III, multicenter, randomized, double-blind, placebo-controlled, parallel-group st

scientific article published on 01 November 2008

European League Against Rheumatism recommendations for the management of psoriatic arthritis with pharmacological therapies

scientific article published on 27 September 2011

OMERACT Rheumatoid Arthritis Magnetic Resonance Imaging Studies. Core set of MRI acquisitions, joint pathology definitions, and the OMERACT RA-MRI scoring system

scientific article

Autologous hematopoietic stem cell transplantation vs intravenous pulse cyclophosphamide in diffuse cutaneous systemic sclerosis: a randomized clinical trial

scientific article published on 25 June 2014